CN102772685B - Traditional Chinese medicinal preparation for treating aplastic anemia - Google Patents
Traditional Chinese medicinal preparation for treating aplastic anemia Download PDFInfo
- Publication number
- CN102772685B CN102772685B CN201210243793.0A CN201210243793A CN102772685B CN 102772685 B CN102772685 B CN 102772685B CN 201210243793 A CN201210243793 A CN 201210243793A CN 102772685 B CN102772685 B CN 102772685B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- grams
- aplastic anemia
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicinal preparation for treating aplastic anemia, which is mainly used for solving the problems that the existing treatment mode for treating aplastic anemia has a bad curative effect and high treatment cost. The traditional Chinese medicinal preparation is characterized by comprising the following ingredients in parts by weight: 10-30 parts of radix rehmanniae, 10-30 parts of cortex moutan, 10-25 parts of liquorice, 10-30 parts of rhizoma imperatae, 10-30 parts of herba cirsii, 10-30 parts of cornu bubali, 10-30 parts of pseudo-ginseng, 10-30 parts of angelica, 10-30 parts of codonopsis pilosula, 10-30 parts of hairyvein agrimonia, 10-30 parts of safflower and 10-30 parts of radix isatidis. The traditional Chinese medicinal preparation for treating aplastic anemia is low in cost, good in curative effect, and not easy to relapse.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation, particularly a kind of Chinese medicine preparation for the treatment of aplastic anemia.
Background technology
Aplastic anemia, is called for short aplastic anemia, be one group because the marrow hemopoietic stem cells due to chemistry, physics, biological factor and unknown cause and (or) hematopoieticmicroenviron-ment damage the one group of syndrome that causes marrow hematopoiesis function failure.Clinical manifestation is pancytopenia and the anemia causing therefrom, hemorrhage and infect.Aplastic anemia is generally divided acute aplastic anemia and chronic aplastic anemia.Mainly there is corresponding clinical symptoms because of pancytopenia, as patient's easy infection of leukopenia, occur heating etc.; Erythrocytopenia and common cardiopalmus, weak, dizzy etc.; Thrombocytopenia is shown in bleeding.General conventional anti-anemic drug is failed to respond to any medical treatment.And medical expense is high, easily recurrence.
Summary of the invention
The invention reside in the mode that overcomes the existing treatment of employing existing in background technology and treat the high problem for the treatment of of aplastic anemia weak effect expense, and provide a kind of Chinese medicine preparation for the treatment of aplastic anemia, this Chinese medicine preparation is with low cost, and good effect is difficult for recurrence.
The present invention solves its problem and can reach by following technical solution: the Chinese medicine preparation of this treatment aplastic anemia, the weight portion of each component and each component is: Radix Rehmanniae 10-30 part, Cortex Moutan 10-30 part, Radix Glycyrrhizae 10-25 part, Rhizoma Imperatae 10-30 part, Herba Cirsii 10-30 part, Cornu Bubali 10-30 part, Radix Notoginseng 10-30 part, Radix Angelicae Sinensis 10-30 part, Radix Codonopsis 10-30 part, Herba Agrimoniae 10-30 part, Flos Carthami 10-30 part, Radix Isatidis 10-30 part.
The Chinese medicine preparation for the treatment of aplastic anemia of the present invention routinely pharmaceutical methods decocting is boiled into decoction and takes.One twice-daily, takes each 200 grams sooner or later.
The routine Patients with Aplastic Anemia of clinical treatment 200, has 172 examples to cure, and cure rate is 86%.
Aplastic anemia is a kind of serious hematologic disease that hemopoietic function of bone marrow obstacle causes.Aplastic anemia belongs to the disease categories such as Chinese medicine " asthenia ", " marrow labor ", " blood disorder ".Chinese medicine thinks, primary disease innate deficiency, lacks of proper care after one's birth, and body constitution weakness, or all sick mistakes control is sickly lost and supported or the internal injury of being overworked for a very long period for a long time, and body and the spirit is crossed consumption, and gradually to vigour loss, essence and blood is empty few, and internal organs hypofunction, due to insufficiency of generating and transforming QI and blood.Need to adopt heat clearing away, removing heat from blood, hemostasis, hemopoietic, treatment by Chinese herbs.The Radix Rehmanniae of the Chinese medicine preparation of this treatment aplastic anemia, the effect that Cortex Moutan has removing heat from blood; Radix Glycyrrhizae can be detoxified; Rhizoma Imperatae hemostasis diuresis; Herba Cirsii, Herba Agrimoniae are for hemostasis; Cornu Bubali heat clearing and blood cooling; Radix Notoginseng, Flos Carthami are used for invigorating blood circulation, stopping blooding; Radix Angelicae Sinensis is used for enriching blood; Radix Codonopsis is for invigorating the spleen and replenishing QI; Radix Isatidis heat-clearing and toxic substances removing.
The Chinese medicine preparation of this treatment aplastic anemia is with low cost, good effect, and instant effect, does not recur, and no side effects is applicable to all kinds of patients.Curative effect is firm, has no adverse reaction, and treatment total effective rate is in 86% left and right.
the specific embodiment:
Below in conjunction with specific embodiment, the present invention is further illustrated:
Embodiment 1
10 grams, 10 grams, the Radix Rehmanniae, 10 grams of Cortex Moutans, 10 grams, Radix Glycyrrhizae, 10 grams of Rhizoma Imperataes, 10 grams of Herba Cirsiis, 10 grams of Cornu Bubalis, 10 grams of Radix Notoginseng, 10 grams of Radix Angelicae Sinensis, 10 grams of Radix Codonopsis, 10 grams of Herba Agrimoniaes, 10 grams, Flos Carthami, Radix Isatidis is added water and decocts into decoction and take.
Embodiment 2
30 grams, 30 grams, the Radix Rehmanniae, 30 grams of Cortex Moutans, 25 grams, Radix Glycyrrhizae, 30 grams of Rhizoma Imperataes, 30 grams of Herba Cirsiis, 30 grams of Cornu Bubalis, 30 grams of Radix Notoginseng, 30 grams of Radix Angelicae Sinensis, 30 grams of Radix Codonopsis, 30 grams of Herba Agrimoniaes, 30 grams, Flos Carthami, Radix Isatidis is added water and decocts into decoction and take.
Embodiment 3
15 grams, 15 grams, the Radix Rehmanniae, 15 grams of Cortex Moutans, 13 grams, Radix Glycyrrhizae, 15 grams of Rhizoma Imperataes, 15 grams of Herba Cirsiis, 15 grams of Cornu Bubalis, 15 grams of Radix Notoginseng, 15 grams of Radix Angelicae Sinensis, 15 grams of Radix Codonopsis, 15 grams of Herba Agrimoniaes, 15 grams, Flos Carthami, Radix Isatidis is added water and decocts into decoction and take.
Embodiment 4
19 grams, 18 grams, the Radix Rehmanniae, 18 grams of Cortex Moutans, 16 grams, Radix Glycyrrhizae, 18 grams of Rhizoma Imperataes, 19 grams of Herba Cirsiis, 19 grams of Cornu Bubalis, 19 grams of Radix Notoginseng, 19 grams of Radix Angelicae Sinensis, 19 grams of Radix Codonopsis, 19 grams of Herba Agrimoniaes, 19 grams, Flos Carthami, Radix Isatidis is added water and decocts into decoction and take.
Case 1: patient: Wang, man 40 years old, Qiqihaer City of Heilongjiang Province, takes this decoction treatment 1 month, and transference cure, without recurrence.
Case 2: patient: Liu so-and-so, female 8 years old, Daqing, Heilongjiang Province, takes this decoction 2 months, disease more, without recurrence.
Case 3: patient: Lee, man 9 years old, Harbin, Heilongjiang Province, takes this decoction 3 months, and more, nothing recurs disease.
Claims (2)
1. a Chinese medicine preparation for the treatment of aplastic anemia, is characterized in that: the component of this Chinese medicine preparation and the weight portion of each component are: Radix Rehmanniae 10-30 part, Cortex Moutan 10-30 part, Radix Glycyrrhizae 10-25 part, Rhizoma Imperatae 10-30 part, Herba Cirsii 10-30 part, Cornu Bubali 10-30 part, Radix Notoginseng 10-30 part, Radix Angelicae Sinensis 10-30 part, Radix Codonopsis 10-30 part, Herba Agrimoniae 10-30 part, Flos Carthami 10-30 part, Radix Isatidis 10-30 part.
2. the Chinese medicine preparation for the treatment of aplastic anemia according to claim 1, is characterized in that: described medicament is to be made up of the raw material of following weight proportion: 15 parts, the Radix Rehmanniae, 15 parts of Cortex Moutans, 13 parts, Radix Glycyrrhizae, 15 parts of Rhizoma Imperataes, 15 parts of Herba Cirsiis, 15 parts of Cornu Bubalis, 15 parts of Radix Notoginseng, 15 parts of Radix Angelicae Sinensis, 15 parts of Radix Codonopsis, 15 parts of Herba Agrimoniaes, 15 parts, Flos Carthami, 15 parts of Radix Isatidis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210243793.0A CN102772685B (en) | 2012-07-16 | 2012-07-16 | Traditional Chinese medicinal preparation for treating aplastic anemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210243793.0A CN102772685B (en) | 2012-07-16 | 2012-07-16 | Traditional Chinese medicinal preparation for treating aplastic anemia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102772685A CN102772685A (en) | 2012-11-14 |
| CN102772685B true CN102772685B (en) | 2014-07-02 |
Family
ID=47117941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210243793.0A Expired - Fee Related CN102772685B (en) | 2012-07-16 | 2012-07-16 | Traditional Chinese medicinal preparation for treating aplastic anemia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102772685B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1390588A (en) * | 2002-08-06 | 2003-01-15 | 王凯 | Composite medicine for treating leukemia |
| CN1879841A (en) * | 2006-05-17 | 2006-12-20 | 郭富红 | A Chinese medicine for treating leukemia |
| CN102512592A (en) * | 2011-12-16 | 2012-06-27 | 河南科技大学第一附属医院 | Traditional Chinese medicine capsule for treating refractory idiopathic thrombocytopenic purpura and preparation method for same |
-
2012
- 2012-07-16 CN CN201210243793.0A patent/CN102772685B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1390588A (en) * | 2002-08-06 | 2003-01-15 | 王凯 | Composite medicine for treating leukemia |
| CN1879841A (en) * | 2006-05-17 | 2006-12-20 | 郭富红 | A Chinese medicine for treating leukemia |
| CN102512592A (en) * | 2011-12-16 | 2012-06-27 | 河南科技大学第一附属医院 | Traditional Chinese medicine capsule for treating refractory idiopathic thrombocytopenic purpura and preparation method for same |
Non-Patent Citations (4)
| Title |
|---|
| 基于中医治疗血液病方剂的数据挖掘;李文涛等;《2011年中国药学大会暨第11届中国药师周论文集》;20111231;全文 * |
| 李文涛等.基于中医治疗血液病方剂的数据挖掘.《2011年中国药学大会暨第11届中国药师周论文集》.2011, |
| 王爱萍等.药物治疗过敏性紫癜的研究进展.《中国药业》.2012,第21卷(第5期), |
| 药物治疗过敏性紫癜的研究进展;王爱萍等;《中国药业》;20120305;第21卷(第5期);全文 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102772685A (en) | 2012-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101284121A (en) | Combination medicine for curing the hoary hair | |
| CN101366892A (en) | Chinese medicinal composition for treating menorrhalgia | |
| CN103933468A (en) | Traditional Chinese medicine for treating acute pancreatitis | |
| CN103784602A (en) | Traditional Chinese medicine for treating iron-deficiency anemia | |
| CN102772685B (en) | Traditional Chinese medicinal preparation for treating aplastic anemia | |
| CN104800389A (en) | External use liquid medicine for treating eczema | |
| CN104435545B (en) | A kind of Chinese medicine preparation for treating caused by benzene leukopenia | |
| CN102114205A (en) | Chinese herbal medicine for treating nephropathy | |
| CN105343518A (en) | Traditional Chinese medicine formula for treating chronic aplastic anemia and preparation method thereof | |
| CN101856423A (en) | Medicament for treating menoxenia and preparation method thereof | |
| CN105456887A (en) | Pharmaceutical for treating aplastic anemia | |
| CN105641414A (en) | A traditional Chinese medicine preparation for treating diabetic nephropathy and a preparing method thereof | |
| CN105311460A (en) | Traditional Chinese medicine for treating vascular neuralgia headache | |
| CN103800664A (en) | Traditional Chinese medicine composition for treating menopausal syndrome | |
| CN102727765A (en) | Internally-used medicine for treating aplastic anemia by nourishing yin and yang | |
| CN102727710B (en) | Medicine for treating aplastic anemia | |
| CN102309648A (en) | Traditional Chinese medicine prescription for treating postpartum retention of lochia | |
| CN103751607A (en) | Traditional Chinese medicine composition for the treatment of aplastic anemia | |
| CN103599482B (en) | A kind of Chinese medicine for the treatment of lochiorrhea | |
| CN103845555A (en) | Traditional Chinese medicine for treating lumbocrural pain | |
| CN103550359B (en) | Jaundice clearing traditional Chinese medicine for children | |
| CN103386071A (en) | A Chinese herbal medicine combination for treating leukemia | |
| CN103845553A (en) | Traditional Chinese medicine for treating myocarditis | |
| CN103285289A (en) | Traditional Chinese medicine for treating arthralgia | |
| CN102908598B (en) | Medicine for treating children fungal pneumonia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140702 Termination date: 20150716 |
|
| EXPY | Termination of patent right or utility model |